NeuroSense CFO Eisenberg joins ROTH Healthcare Opportunities Conference investor meetings
NRSN•NeuroSense will attend the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29, 2026, where CFO Or Eisenberg is scheduled to meet investors and discuss PrimeC clinical and regulatory progress and potential approval plans in Canada and the U.S.
1. Investor meetings planned
NeuroSense will attend the conference in New York City on Sept. 29, 2026. CFO Or Eisenberg is scheduled for one-on-one and small-group meetings with institutional investors focused on PrimeC's clinical and regulatory progress, including plans to pursue potential approvals in Canada and the U.S.
